Interrelații microbiota intestinală – gazdă
Direcții de cercetare
- Determinarea profilului microbiotei pacienților cu diverse afecțiuni folosind tehnici moderne si inovatoare de metagenomică cantitativă
- Modalitati terapeutice si nutritionale emergente in diabezitate
Persoană de contact:
Prof. univ. dr. Mihai COVAȘĂ
mcovasa@usm.ro
Echipa de cercetare:
- Prof. univ. dr. Mihai COVAȘĂ,
- Prof. univ. dr. Mihai DIMIAN,
- Conf. univ. dr. biol. Andrei LOBIUC,
- Conf. univ. dr. Roxana FILIP,
- Conf. univ. dr. Olga CĂLIMAN STURDZA,
- Șl dr. Roxana GHEORGHIȚĂ,
- Asist. univ. Delia PINTILEI-REUREAN,
- Asist. univ. dr. Monica IAVORSCHI
- Laborant chimist Naomi PAVĂL
Publicații:
- Anchidin-Norocel, L; Iatcu, OC; Lobiuc, A; Covasa, M, 2025, Heavy Metal-Gut Microbiota Interactions: Probiotics Modulation and Biosensors Detection, BIOSENSORS-BASEL
Hamamah, S; Iatcu, OC; Covasa, M, 2025, Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), NUTRIENTS - Lobiuc, A; Groppa, L; Chislari, L; Russu, E; Homitchi, M; Ciorescu, C; Hamamah, S; Bran, IC; Covasa, M, 2025, Gut microbiota and ankylosing spondylitis: current insights and future challenges, MICROBIAL CELL
- Iatcu, OC; Hamamah, S; Covasa, M, 2024, Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes, NUTRIENTS
- Hamamah, S; Hajnal, A; Covasa, M, 2024, Influence of Bariatric Surgery on Gut Microbiota Composition and Its Implication on Brain and Peripheral Targets, NUTRIENTS
- Hamamah, S; Iatcu, OC; Covasa, M, 2024, Nutrition at the Intersection between Gut Microbiota Eubiosis and Effective Management of Type 2 Diabetes, NUTRIENTS
- Hamamah, S; Amin, A; Al-Kassir, AL; Chuang, J; Covasa, M, 2023, Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake, NUTRIENTS
- Flaig, B; Garza, R; Singh, B; Hamamah, S; Covasa, M, 2023, Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota, NUTRIENTS
- Salmen, T; Pietrosel, VA; Urzica, FV; Visan, DE; Salmen, BM; Cimpeanu, RC; Reurean-Pintilei, D; Popoviciu, MS; Stoian, AP, 2025, Evaluating Cardio-Protective Molecules by Efficacy Based on Weight Reduction and HbA1c Targets, BIOMEDICINES
- Popoviciu, MS; Reurean-Pintilei, D; Salmen, T; Rus, M; Ferician, A; Sava, C; Ardelean, AI; Moroianu, LA; Stoian, AP, 2025, Translating Guidelines into Practice: A Prospective Real-World Study of a Romanian Cohort Treated with GLP-1 RAs, BIOMEDICINES
- Popoviciu, MS; Salmen, T; Reurean-Pintilei, D; Voiculescu, V; Stoian, AP, 2025, SGLT-2i-A Useful Tool for Real-Life Metabolic and Body Weight Control in Type 2 Diabetes Mellitus Patients, MEDICINA-LITHUANIA
- Stefan, AG; Clenciu, D; Vladu, IM; Mitrea, A; Protasiewicz-Timofticiuc, DC; Rosu, MM; Gheonea, TC; Vladu, BE; Efrem, IC; Pintilei, DVR; Mota, E; Mota, M, 2025, Relationship Between Insulin Resistance Indicators and Type 2 Diabetes Mellitus in Romania, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Salmen, T; Pietrosel, VA; Reurean-Pintilei, D; Iancu, MA; Cimpeanu, RC; Bica, IC; Dumitriu-Stan, RI; Potcovaru, CG; Salmen, BM; Diaconu, CC; Cretoiu, SM; Stoian, AP, 2024, Assessing Cardiovascular Target Attainment in Type 2 Diabetes Mellitus Patients in Tertiary Diabetes Center in Romania, PHARMACEUTICALS
- Reurean-Pintilei, D; Potcovaru, CG; Salmen, T; Mititelu-Tartau, L; Cinteza, D; Lazar, S; Stoian, AP; Timar, R; Timar, B, 2024, Assessment of Cardiovascular Risk Categories and Achievement of Therapeutic Targets in European Patients with Type 2 Diabetes, JOURNAL OF CLINICAL MEDICINE
- Popoviciu, MS; Paduraru, L; Rahman, MM; Supti, FA; Stoica, RA; Reurean-Pintilei, D; Bica, CI; Cavalu, S, 2024, The effects of SGLT2 inhibitors in patients with metabolic dysfunction-associated fatty liver disease; a narrative review, JOURNAL OF MIND AND MEDICAL SCIENCES
- Boariu, S; Scutariu, AM; Cureniuc, A; Meauca, A; Stoica, RA; Stoian, AP; Pintilei, DR, 2023, Follow-up care after metabolic surgery – a prospective study in the North-Eastern region of Romania, JOURNAL OF MIND AND MEDICAL SCIENCES
